| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.27 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |